期刊文献+

肥厚梗阻性心肌病合并二尖瓣狭窄的外科治疗 被引量:2

Surgical treatment for hypertrophic obstructive cardiomyopathy associated with mitral stenosis
下载PDF
导出
摘要 目的:研究肥厚梗阻性心肌病合并二尖瓣狭窄患者的治疗效果和预后。方法:回顾性分析2000年1月至2016年7月间,我院收治的肥厚梗阻性心肌病合并二尖瓣狭窄的患者共7例,其中男性4例,女性3例,年龄35.4~64.8岁,平均(52.6±9.0)岁。通过门诊随访的方式记录患者的心功能、左心房大小、跨瓣压差和射血分数等,并记录主要并发症。结果:全组无围术期死亡病例,1例安装永久起搏器。术后住院天数7.0~14.0d,平均(10.3±2.9)d,体外循环时间65.0~177.0min,平均(125.9±36.0)min,阻断时间40.0~122.0min,平均(93.6±29.9)min。术后病理显示二尖瓣全部为风湿性改变。超声显示二尖瓣人工瓣膜功能良好,左心室流出道压差均下降至正常。随访)2.5~115.9个月,平均(72.1±36.9)个月,1例出现三尖瓣大量反流,1例出现急性脑梗死。二尖瓣功能良好,左心室流出道压差均正常,心功能分级(NYHA)I级5例,II级2例,较前明显改善。结论:肥厚型心肌病合并二尖瓣狭窄的患者其术后效果满意,远期预后需一步随访。 Objective: To study the clinical results of treatment for hypertrophic obstructive cardiomyop- athy ( HOCM ) associated with mitral stenosis ( MS ). Methods : Retrospectively analyze the patients with HOCM plus MS in our hospital from 2006. 1 to 2016. 7. There are 4 male and 3 female patients in this group. Mean age was 35.4-64. 8 (52. 6 ± 9.0) years. The clinical parameters were recorded through outpatient clinic and telephones. Results:There was no death case throughout the postoperative and follow-up time. One patient undertaken permanent pacemaker implantation postoperatively. Mean postoperative stay in hospital was 7.0- 14. 0 ( 10. 3 ± 2. 99)days, mean cardiopulmonary bypass time was 65.0-177.0 ( 125.9 ± 36. 0) minutes, mean cross-clamping time was 40. 0-122. 0 (93. 6 ± 29. 9)minutes. Postoperative pathology showed rheumatic lesions in all cases. Mean follow-up time was 2.5-115.9 (72. 1 ± 36. 9)months. There was one case with severe tricus- pid insufficiency and one with acute cerebral infarction. All the prosthesis functioned well. Five patients had NYHA class I and two had NYHA class II. The heart functions were improved. Conclusion:The clinical results of HOCM associated with MS have a good prognosis.
出处 《心肺血管病杂志》 2017年第4期273-276,共4页 Journal of Cardiovascular and Pulmonary Diseases
关键词 肥厚型心肌病 二尖瓣狭窄 治疗效果 Hypertrophic cardiomyopathy Mitral stenosis Clinical results
  • 相关文献

参考文献4

二级参考文献51

  • 1高明明.肥厚型心肌病的遗传学研究进展[J].心肺血管病杂志,1995,14(1):61-62. 被引量:2
  • 2廖玉华.从心肌病病因学研究走向临床诊断与治疗实践[J].中华心血管病杂志,2007,35(1):1-2. 被引量:26
  • 3周永昌 郭万学.超声医学[M].北京:科技文献出版社,1997.74. 被引量:36
  • 4Ho CY,Seidman CE.A contemporary approach to hypertrophic cardiomyopathy.Circulation,2006,1 1 3:e858-862. 被引量:1
  • 5Knollmann BC,Chopra N,Hlaing T,et al.Casq2 deletion causes sarcoplasmic reticulum volume increase,premature Ca2 + release,and catecholaminergic polymorphic ventricular tachycardia.J Clin Invest,2006,116:2510-2520. 被引量:1
  • 6Elliott K,Watkins H,Redwood CS.Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy.J Biol Chem,2000,275:22069-22074. 被引量:1
  • 7Morner S,Richard P,Kazzam E,et al.Deletion in the cardiac troponin I gene in a family from northern Sweden with hypertophic cardiomyopathy.J Mol Cell Cardiol,2000,32:521-525. 被引量:1
  • 8Tsoutsman T,Chung J,Doolan A,et al.Molecular insights from a novel cardiac troponin I muse model of familial hypertrophic cardiomyopathy.J Mol Cell Cardiol,2006,41:623-632. 被引量:1
  • 9Anan R,Shono H,Kisanuki A,et al.Patients with familial bypertrophic cardiomyopathy caused by a Phe110Ile missense mutation in the cardiac troponin T gene have variable cardiac morphologies and a favorable prognosis.Circulation,1998,98:391-397. 被引量:1
  • 10Niimura H,Bachinski LL,Sangwatanaroj S,et al.Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy.N Engl J Med,1998,338:1248-1257. 被引量:1

共引文献32

同被引文献20

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部